How to better predict the effect of your cancer immunotherapy? Tailored-made humanized mouse models are the key solution
Discover & learn during this webinar:
How to design custom-made humanized immune system (HIS) models for cancer immunotherapy research
Case study & results: evaluation of immuno-onco biologics & demonstration of antitumor effect in HIS model
Parameters to consider for HIS model selection
Advantages/limitations of each HIS model
About our speaker Caroline Mignard Caroline Mignard has obtained a Ph.D in Biology from the University of Strasbourg in France and has more than 15 years of experience in preclinical research.
As study director at Oncodesign, Caroline has been working closely with our clients to select the most appropriate study designs for the evaluation of their therapies through preclinical studies.
Caroline is also involved in IMODI, (Innovative MODels Initiative) a French consortium dedicated to the development, the characterization and the commercialization of new preclinical models in oncology, including PDX models and humanized mouse models. She is the co-author of several publications about PDX models.
Conference animated by :
Business & Marketing,
Marketing & Communication Manager,
Tuesday, January 29th 2019
from 5:00PM to 5:45PM
65 subscribers | 45 mins
Subscription 100% free
Email notifications before the webinar
Chat zone to ask your questions
Replay until February 1, 2020
Be informed of our upcoming webinars, subscribe to our channel.
For which account do you want to create a webinar?
Select a reservation
Have you booked a date and a time slot with your Marketing Manager? Please select it.
Create a new webinar
Your subscription seems to have ended. To continue creating webinars, contact your Marketing Manager.
services related to your interests.